Subscribe
Funding & M&A
8 min read

Central Pet Distribution Spins Out as Phillips-Led JV, Moving Pet Specialty Into Consolidation Sprint

Central Garden & Pet is combining its pet distribution operations with Phillips Pet Food & Supplies in a new JV, retaining a 20% minority stake while Axar Capital-led investors control 80%. The deal reflects accelerating consolidation in pet specialty distribution.

Written by
The Underbite
Published on
April 14, 2026
Central Pet Distribution Spins Out as Phillips-Led JV, Moving Pet Specialty Into Consolidation Sprint

Central Garden & Pet is exiting the distribution business via a strategic partnership that folds its pet supply operations into a new Phillips-led joint venture, joining a wave of PE-backed consolidation reshaping how pet specialty retailers stock shelves.

Central announced the deal on April 13, with the newly formed entity retaining the Phillips brand and operating as an independent company. The move marks a significant portfolio shift for the publicly traded company: it's cashing out a major distribution operation while taking a minority 20% stake in the combined platform.

What Happened

Central Garden & Pet and Phillips Pet Food & Supplies have created a strategic joint venture that combines pet specialty distribution operations into a single nationalized platform. The JV operates under the Phillips brand with Blaine Phillips, CEO and Chairman of Phillips, at the helm.

In the transaction structure, Central receives cash proceeds and maintains a 20% ownership stake going forward. Phillips and co-investors led by Axar Capital Management hold the remaining 80% of the combined entity, positioning Axar as the PE anchor behind the consolidation play.

Phillips already operates 11 distribution centers serving the pet specialty channel across multiple geographies. The integration absorbs Central's pet distribution operations and personnel, who are expected to transition to the new entity. The combined footprint creates what the companies describe as a "more consolidated nationwide pet specialty distribution platform."

For Central, this is a partial exit from the distribution business. The company will retain its expertise in pet food and companion animal supply manufacturing but shed the capital-intensive logistics operations. Central founder and chairman Robert Cattoi built the company (founded 1980) into a roughly $3.3 billion annual revenue enterprise spanning production, brands, and distribution. This JV signals a reset around core manufacturing and brand assets.

The timing reflects mounting pressure on mid-market distributors to either scale up or get out. Phillips' independent retail footprint and Central's distribution infrastructure create operational synergies, but the deal is fundamentally about consolidation: reducing the number of vendors specialty retailers have to manage.

Why It Matters

1. Pet specialty distribution is consolidating fast. The channel has fragmented for years, with multiple regional and national players complicating purchasing decisions for retailers. This JV creates a more streamlined alternative. When retailers can consolidate vendors, they gain negotiating leverage and operational simplicity, both powerful drivers in a channel where margins matter.

2. PE interest in pet distribution remains white-hot. Private equity has made eight pet-related deals in 2026 year-to-date, compared to five for all of 2025, citing Capstone Partners data. The sector attracted roughly $500 million in PE-backed deal volume last year alone.

3. Central's exit recalibrates its portfolio toward manufacturing. For a $3.3 billion diversified company, distribution is a cash-intensive, margin-compressed business relative to branded goods and manufacturing.

4. Specialty retail gets a credible counterweight. Independent pet specialty retailers, roughly a $15 billion channel segment, have been feeling the squeeze from Chewy's vertical integration and logistics advantage for years.

5. This deal could reshape wholesale price dynamics. When distributor consolidation accelerates, suppliers face fewer, more powerful buyers, and that historically means price compression upstream.

What to Watch

Monitor Central Garden & Pet's next earnings call for color on how the JV impacts the parent company's financial profile and strategic priorities.

Track whether other mid-market distributors follow suit. If the Phillips model works (combining regional expertise with PE capital and operational support), it could spark additional roll-up announcements.

Source: Central Garden & Pet and Phillips Pet Food & Supplies joint venture announcement via Business Wire

See every deal in the Pet Industry M&A Tracker →

Subscribe to newsletter

Join our newsletter to stay up to date on features and releases.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.

What's Happening

Other News

More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.

Read article
Vetspire Splits From Thrive, Lands a Battery Ventures Backing
Funding & M&A
4 min read

Vetspire Splits From Thrive, Lands a Battery Ventures Backing

Vetspire has spun out of Thrive Pet Healthcare's orbit with a growth investment from Battery Ventures and a new CEO, Zachary Seely. The AI-powered practice management platform, used by more than 800 veterinary hospitals and clinics, will operate independently while Thrive remains a customer. The deal tests whether AI-native vet software can draw institutional capital without a strategic parent underwriting it.

Read article
Read article
PetMeds Revenue Falls 20% as Takeover Fight Drags On
Earnings
6 min read

PetMeds Revenue Falls 20% as Takeover Fight Drags On

PetMeds' first-quarter revenue fell 19.9% to $41.0 million and cash reserves dropped to $13.1 million, even as the company narrowed its net loss to $6.1 million from $34.2 million a year earlier. The results land as an unsolicited $3-a-share buyout offer from SilverCape Investments remains on the table and a $37 million sale-leaseback of its headquarters awaits closing.

Read article
Read article
FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North
Regulatory
4 min read

FDA Clears Zoetis Drug for Screwworm as Outbreak Spreads North

The FDA granted Zoetis an emergency use authorization for Simparica Trio to treat New World screwworm in dogs, the first product cleared specifically for the threat. Texas has already begun requiring treatment before dogs cross certain lines, putting boarding facilities, transporters, and border-state vet practices under a new compliance mandate.

Read article
View all articles